WEST VIRGINIA UNIVERSITY
Development of anti-LPS therapeutic antibodies for the treatment of Pseudomonas aeruginosa infections
Development of anti-LPS therapeutic antibodies for the treatment of Pseudomonas aeruginosa infections is a funding opportunity from WEST VIRGINIA UNIVERSITY, up to 2779955, closing July 31, 2029.
Jul 31, 2029
(1096d left)Overview
SUMMARY The goal of this proposal is to develop therapeutic antibodies for the treatment of multidrug resistant (MDR) P. aeruginosa infections, with an emphasis on sepsis. With the rise in antimicrobial resistance around the world we are running out of therapeutic options against MDR P. aeruginosa. Our laboratory has…